PL395510A1 - Szczepionka wirusowa przeciwko infekcji wirusowej lub wielonarządowemu poodsadzeniowemu zespołowi wyniszczającemu wywoływanemu przez PCV2, jej zastosowanie, zakaźny molekularny klon DNA PCV2 oraz zawierający go biologicznie funkcjonalny plazmid lub wektor wirusowy - Google Patents
Szczepionka wirusowa przeciwko infekcji wirusowej lub wielonarządowemu poodsadzeniowemu zespołowi wyniszczającemu wywoływanemu przez PCV2, jej zastosowanie, zakaźny molekularny klon DNA PCV2 oraz zawierający go biologicznie funkcjonalny plazmid lub wektor wirusowyInfo
- Publication number
- PL395510A1 PL395510A1 PL395510A PL39551002A PL395510A1 PL 395510 A1 PL395510 A1 PL 395510A1 PL 395510 A PL395510 A PL 395510A PL 39551002 A PL39551002 A PL 39551002A PL 395510 A1 PL395510 A1 PL 395510A1
- Authority
- PL
- Poland
- Prior art keywords
- pcv2
- viral
- organ
- dna clone
- vector containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34077501P | 2001-12-12 | 2001-12-12 | |
| US42484002P | 2002-11-08 | 2002-11-08 | |
| US10/314,512 US7276353B2 (en) | 2001-12-12 | 2002-12-09 | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL395510A1 true PL395510A1 (pl) | 2011-12-19 |
Family
ID=27405726
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL395510A PL395510A1 (pl) | 2001-12-12 | 2002-12-11 | Szczepionka wirusowa przeciwko infekcji wirusowej lub wielonarządowemu poodsadzeniowemu zespołowi wyniszczającemu wywoływanemu przez PCV2, jej zastosowanie, zakaźny molekularny klon DNA PCV2 oraz zawierający go biologicznie funkcjonalny plazmid lub wektor wirusowy |
| PL395509A PL215058B1 (pl) | 2001-12-12 | 2002-12-11 | Szczepionka wirusowa przeciwko infekcji wirusowej lub wielonarzadowemu poodsadzeniowemu zespolowi wyniszczajacemu wywolywanemu przez PCV2 oraz jej zastosowania |
| PL374382A PL214803B1 (pl) | 2001-12-12 | 2002-12-11 | Zakazna chimerowa czasteczka kwasu nukleinowego cirkowirusa swini PCV1-2, sposób jej wytwarzania, zawierajacy ja plazmid lub wektor wirusowy i komórka gospodarza, oraz chimerowy cirkowirus swini, sposób wytwarzania immunogennego produktu polipeptydowego, szczepionka wirusowa i jej zastosowanie, zakazna odwrotna chimerowa czasteczka kwasu nukleinowego cirkowirusa swini PCV1-2 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL395509A PL215058B1 (pl) | 2001-12-12 | 2002-12-11 | Szczepionka wirusowa przeciwko infekcji wirusowej lub wielonarzadowemu poodsadzeniowemu zespolowi wyniszczajacemu wywolywanemu przez PCV2 oraz jej zastosowania |
| PL374382A PL214803B1 (pl) | 2001-12-12 | 2002-12-11 | Zakazna chimerowa czasteczka kwasu nukleinowego cirkowirusa swini PCV1-2, sposób jej wytwarzania, zawierajacy ja plazmid lub wektor wirusowy i komórka gospodarza, oraz chimerowy cirkowirus swini, sposób wytwarzania immunogennego produktu polipeptydowego, szczepionka wirusowa i jej zastosowanie, zakazna odwrotna chimerowa czasteczka kwasu nukleinowego cirkowirusa swini PCV1-2 |
Country Status (30)
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| CN1749397B (zh) * | 2004-08-18 | 2010-12-08 | 金宁一 | 共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗 |
| US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
| UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| RU2620968C9 (ru) | 2004-12-30 | 2017-08-08 | Берингер Ингельгейм Ветмедика, Инк. | Иммуногенные композиции pcv2 и способы получения таких композиций |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| CN1328373C (zh) * | 2005-04-07 | 2007-07-25 | 南京农业大学 | 猪ⅱ型圆环病毒重组腺病毒 |
| EP1896069B1 (en) * | 2005-06-24 | 2013-03-13 | Intervet International BV | Inactivated chimeric vaccines and related methods of use |
| CN101277717A (zh) | 2005-09-09 | 2008-10-01 | 英特威国际有限公司 | Pcv-2疫苗 |
| CA2635430A1 (en) * | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| DK2275132T3 (da) | 2005-12-29 | 2021-05-17 | Boehringer Ingelheim Animal Health Usa Inc | Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem |
| JP4625485B2 (ja) * | 2006-09-29 | 2011-02-02 | 財団法人大阪産業振興機構 | 高病原性トリインフルエンザウイルスに対するモノクローナル抗体 |
| WO2008064299A2 (en) * | 2006-11-22 | 2008-05-29 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
| WO2008073464A2 (en) | 2006-12-11 | 2008-06-19 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| EP1941903A1 (en) * | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
| EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
| AU2008294036A1 (en) * | 2007-05-30 | 2009-03-05 | Wyeth Llc | Raccoon poxvirus expressing genes of porcine virus |
| US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| US7829274B2 (en) * | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| US9056909B2 (en) * | 2007-11-06 | 2015-06-16 | Zoetis Services Llc | Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine |
| CA2710247C (en) * | 2007-12-21 | 2014-02-18 | Wyeth Llc | Methods and compositions for immunizing pigs against porcine circovirus |
| CN101932336B (zh) * | 2007-12-31 | 2014-07-09 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 有外来氨基酸插入的pcv2 orf2病毒样颗粒 |
| KR20100113582A (ko) | 2008-01-23 | 2010-10-21 | 베링거잉겔하임베트메디카인코퍼레이티드 | Pcv2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법 |
| EP2254595A4 (en) * | 2008-02-15 | 2012-12-05 | Boehringer Ingelheim Vetmed | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES |
| KR20100135903A (ko) * | 2008-04-16 | 2010-12-27 | 버지니아 테크 인터렉추얼 프라퍼티스, 인크. | 키메라 돼지 써코바이러스 PCV2Gen―1Rep 및 이의 용도 |
| TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
| HUE047972T2 (hu) | 2010-03-16 | 2020-05-28 | Virginia Tech Intellectual Properties Inc | Gyengített, élõ kiméra sertés cirkovírus vakcina |
| TWI508974B (zh) | 2010-12-22 | 2015-11-21 | Sbc Virbac Ltd | 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用 |
| US20130313127A1 (en) | 2010-12-28 | 2013-11-28 | The University Of Tokyo | Organic compound hydrogenation device and hydrogenation method |
| HUP1100470A2 (en) * | 2011-08-30 | 2013-03-28 | Mezoegazdasagi Biotechnologiai Kutatokoezpont | Nanoparticle-based veterinary vaccine |
| UA113192C2 (xx) | 2011-12-06 | 2016-12-26 | Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2) | |
| UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| KR102217387B1 (ko) * | 2013-03-11 | 2021-02-19 | 주식회사 중앙백신연구소 | 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법 |
| CA2925281C (en) | 2013-09-25 | 2022-05-03 | Zoetis Services Llc | Pcv2b divergent vaccine composition and methods of use |
| ES2778425T3 (es) | 2013-10-02 | 2020-08-10 | Boehringer Ingelheim Animal Health Usa Inc | Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta |
| CN103602759B (zh) * | 2013-11-22 | 2015-09-23 | 福建省农业科学院畜牧兽医研究所 | 一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法 |
| PL3076996T3 (pl) | 2013-12-03 | 2020-05-18 | Intervet International B.V. | Szczepionka przeciwko cirkowirusowi świń typu 2 |
| MX2018010796A (es) * | 2016-03-07 | 2019-01-14 | Virginia Tech Intellectual Properties Inc | Vacunas de circovirus porcino quimerico tipo 2 (pcv2). |
| CN106497892A (zh) * | 2016-09-07 | 2017-03-15 | 扬州大学 | 带KT3标签的重组病毒rPCV2‑KT3的构建方法 |
| CN119488586A (zh) | 2018-03-26 | 2025-02-21 | 勃林格殷格翰动物保健美国有限公司 | 制备免疫原性组合物的方法 |
| CN112898435B (zh) * | 2021-01-14 | 2023-03-31 | 山西农业大学 | 一种可溶性融合蛋白DT390-Cap及其制备方法与应用 |
| AR132582A1 (es) | 2023-05-03 | 2025-07-16 | Boehringer Ingelheim Vetmedica Gmbh | Método para inducir una respuesta inmunitaria |
| EP4704977A1 (en) | 2023-05-03 | 2026-03-11 | Boehringer Ingelheim Vetmedica GmbH | Immunogenic composition useful for self-administration by pigs |
| US20250332242A1 (en) | 2024-04-30 | 2025-10-30 | Zoetis Services Llc | Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use |
| US20250332243A1 (en) | 2024-04-30 | 2025-10-30 | Zoetis Services Llc | Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines |
| WO2026099754A1 (en) | 2024-11-06 | 2026-05-15 | Boehringer Ingelheim Vetmedica Gmbh | Method for reducing virus shedding, tissue colonization, and lymphoid depletion caused by or associated with pcv2 infection |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
| FR2769321B1 (fr) | 1997-10-03 | 2001-10-26 | Merial Sas | Nouveaux circovirus porcins, vaccins et reactifs de diagnostics |
| FR2781159B1 (fr) | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
| UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| FR2769322B1 (fr) | 1997-10-03 | 2002-03-08 | Merial Sas | Nouveaux circovirus porcins, vaccins et reactifs de diagnostic |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| JP3795751B2 (ja) * | 1997-12-11 | 2006-07-12 | ユニバーシティ オブ サスカッチェワン | ブタからの離乳後多全身系消耗症候群ウイルス |
| WO1999045956A1 (en) | 1998-03-13 | 1999-09-16 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
| US6497883B1 (en) * | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
| US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| WO2001083737A2 (en) | 2000-05-03 | 2001-11-08 | University Of Guelph | Porcine adenovirus type 5 vector and vaccine |
| JP2003533989A (ja) * | 2000-05-24 | 2003-11-18 | メリアル | ブタ生殖・呼吸症候群ウィルス(prrsv)の組換えポックスウィルスワクチン |
| WO2001096377A2 (en) | 2000-06-15 | 2001-12-20 | Purdue Research Foundation | Vaccine for congenital tremors in pigs |
| DE10044648A1 (de) * | 2000-09-08 | 2002-03-21 | Aventis Behring Gmbh | Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material |
| MY146518A (en) * | 2001-03-27 | 2012-08-15 | Univ Saskatchewan | Methods to culture circovirus. |
| AUPR567401A0 (en) | 2001-06-14 | 2001-07-12 | University Of Melbourne, The | Circovirus vaccines |
-
2002
- 2002-12-09 US US10/314,512 patent/US7276353B2/en not_active Expired - Lifetime
- 2002-12-11 CN CN201210306454.2A patent/CN103536911B/zh not_active Expired - Lifetime
- 2002-12-11 RS YUP-517/04A patent/RS51288B/sr unknown
- 2002-12-11 HR HRP20140002AA patent/HRP20140002B1/hr not_active IP Right Cessation
- 2002-12-11 CA CA2469599A patent/CA2469599C/en not_active Expired - Lifetime
- 2002-12-11 PT PT02797280T patent/PT1487483E/pt unknown
- 2002-12-11 PL PL395510A patent/PL395510A1/pl not_active Application Discontinuation
- 2002-12-11 HR HRP20040626AA patent/HRP20040626B9/hr not_active IP Right Cessation
- 2002-12-11 DK DK10184702.8T patent/DK2264050T3/en active
- 2002-12-11 SI SI200231091T patent/SI2264050T1/sl unknown
- 2002-12-11 EP EP18175133.0A patent/EP3388515A1/en active Pending
- 2002-12-11 DE DE60238278T patent/DE60238278D1/de not_active Expired - Lifetime
- 2002-12-11 NZ NZ567688A patent/NZ567688A/en not_active IP Right Cessation
- 2002-12-11 LT LTEP10184702.8T patent/LT2264050T/lt unknown
- 2002-12-11 SI SI200231053T patent/SI2263689T1/sl unknown
- 2002-12-11 EP EP10184612.9A patent/EP2263689B1/en not_active Expired - Lifetime
- 2002-12-11 PT PT10184702T patent/PT2264050T/pt unknown
- 2002-12-11 PL PL395509A patent/PL215058B1/pl unknown
- 2002-12-11 JP JP2003550754A patent/JP4623964B2/ja not_active Expired - Lifetime
- 2002-12-11 MX MXPA04005364A patent/MXPA04005364A/es active IP Right Grant
- 2002-12-11 AU AU2002362147A patent/AU2002362147C1/en not_active Expired
- 2002-12-11 HU HU1800263A patent/HU231162B1/hu active Protection Beyond IP Right Term
- 2002-12-11 PL PL374382A patent/PL214803B1/pl not_active IP Right Cessation
- 2002-12-11 HU HU0501000A patent/HU228584B1/hu active Protection Beyond IP Right Term
- 2002-12-11 HR HRP20140003AA patent/HRP20140003B1/hr not_active IP Right Cessation
- 2002-12-11 EP EP10184771A patent/EP2263690A3/en not_active Withdrawn
- 2002-12-11 CN CN02828049.0A patent/CN1620310B/zh not_active Expired - Lifetime
- 2002-12-11 ES ES02797280T patent/ES2355814T3/es not_active Expired - Lifetime
- 2002-12-11 ES ES10184612.9T patent/ES2529726T3/es not_active Expired - Lifetime
- 2002-12-11 HU HU1600373A patent/HU231018B1/hu unknown
- 2002-12-11 NZ NZ533256A patent/NZ533256A/en not_active IP Right Cessation
- 2002-12-11 AT AT02797280T patent/ATE487490T1/de active
- 2002-12-11 PT PT101846129T patent/PT2263689E/pt unknown
- 2002-12-11 ME MEP-2008-177A patent/ME00126B/me unknown
- 2002-12-11 DK DK02797280.1T patent/DK1487483T3/da active
- 2002-12-11 HU HU1300097A patent/HU230576B1/hu unknown
- 2002-12-11 DE DE201112100001 patent/DE122011100001I1/de active Pending
- 2002-12-11 ES ES10184702.8T patent/ES2694505T3/es not_active Expired - Lifetime
- 2002-12-11 BR BRPI0214919A patent/BRPI0214919B1/pt not_active IP Right Cessation
- 2002-12-11 SI SI200230932T patent/SI1487483T1/sl unknown
- 2002-12-11 KR KR1020047009126A patent/KR101014544B1/ko not_active Expired - Lifetime
- 2002-12-11 WO PCT/US2002/039646 patent/WO2003049703A2/en not_active Ceased
- 2002-12-11 EP EP02797280A patent/EP1487483B1/en not_active Expired - Lifetime
- 2002-12-11 EP EP10184702.8A patent/EP2264050B1/en not_active Expired - Lifetime
- 2002-12-11 CA CA2784260A patent/CA2784260C/en not_active Expired - Lifetime
- 2002-12-11 DK DK10184612.9T patent/DK2263689T3/en active
- 2002-12-12 TW TW091135955A patent/TWI314580B/zh not_active IP Right Cessation
-
2004
- 2004-06-10 CO CO04054666A patent/CO5590938A2/es unknown
-
2008
- 2008-05-27 AU AU2008202333A patent/AU2008202333B2/en not_active Expired
-
2011
- 2011-02-03 CY CY20111100127T patent/CY1111167T1/el unknown
- 2011-02-25 AU AU2011200843A patent/AU2011200843B2/en not_active Expired
- 2011-04-29 BE BE2011C008C patent/BE2011C008I2/fr unknown
- 2011-05-02 LU LU91814C patent/LU91814I2/fr unknown
- 2011-05-03 FR FR11C0014C patent/FR11C0014I2/fr active Active
- 2011-05-06 CY CY2011004C patent/CY2011004I2/el unknown
- 2011-05-06 NL NL300480C patent/NL300480I2/nl unknown
-
2018
- 2018-11-05 CY CY181101151T patent/CY1121112T1/el unknown
-
2021
- 2021-09-14 HU HUS2100036C patent/HUS2100036I1/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100036I1 (hu) | Kiméra fertõzõ DNS-klónok, kiméra sertés cirkovírusok, és alkalmazásuk | |
| WO2005092069A3 (en) | Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof | |
| HUP0102770A2 (hu) | Sertésircovírus-antigént és sertésparvovírus-antigént tartalmazó vakcina | |
| DK1037909T3 (da) | Postweaning multisystemisk wasting-syndromvirus (PMWS) fra svin | |
| AU2009236669B2 (en) | Chimeric porcine circovirus PCV2Gen-1Rep and uses thereof | |
| CA2305623A1 (fr) | Circovirus porcins, vaccins et reactifs de diagnostic | |
| EP1298139A3 (en) | Avian herpes virus-based recombinant infectious bursal disease vaccine | |
| AP2002002685A0 (en) | Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents | |
| CY1116098T1 (el) | Χιμαιρικοι μολυσματικοι κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |